Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
Conditions: Coronary Artery Disease; Cardiovascular Diseases; Coronary Disease; Myocardial Ischemia; Arteriosclerosis; Vascular Disease Occlusive Interventions: Procedure: VRS100 robotic-assisted PCI; Procedure: Manual PCI Sponsors: Shenzhen Raysight Intelligent Medical Technology Co., Ltd.; Shanghai Zhongshan Hospital; West China Hospital; Shenzhen People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015)
Conditions: Arteriosclerosis; Hypercholesterolaemia Interventions: Drug: MK-0616; Drug: Placebo Sponsor: Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials